These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19277857)

  • 1. HIV Tat potentiates cell toxicity in a T cell model for sulphamethoxazole-induced adverse drug reactions.
    Adeyanju K; Krizova A; Gilbert PA; Dekaban GA; Rieder M
    Virus Genes; 2009 Jun; 38(3):372-82. PubMed ID: 19277857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 tat expression and sulphamethoxazole hydroxylamine mediated oxidative stress alter the disulfide proteome in Jurkat T cells.
    Adeyanju K; Bend JR; Rieder MJ; Dekaban GA
    Virol J; 2018 May; 15(1):82. PubMed ID: 29743079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat.
    Arp J; Rieder MJ; Urquhart B; Freeman D; Tucker MJ; Krizova A; Lehmann D; Dekaban GA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1218-25. PubMed ID: 15933158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.
    Wijsman JA; Dekaban GA; Rieder MJ
    J Clin Pharmacol; 2005 Mar; 45(3):346-51. PubMed ID: 15703369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.
    Carr A; Tindall B; Penny R; Cooper DA
    Clin Exp Immunol; 1993 Oct; 94(1):21-5. PubMed ID: 8403509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.
    Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ
    FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
    Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
    Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells.
    Rieder MJ; Krause R; Bird IA; Dekaban GA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):134-40. PubMed ID: 7834397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells.
    Lacombe B; Morel M; Margottin-Goguet F; Ramirez BC
    J Virol; 2016 Dec; 90(23):10972-10980. PubMed ID: 27681137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of T-lymphocyte proliferation by sulphonamide hydroxylamines.
    Rieder MJ; Sisson E; Bird IA; Almawi WY
    Int J Immunopharmacol; 1992 Oct; 14(7):1175-80. PubMed ID: 1452402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Tat-induced bystander apoptosis in Jurkat cells involves unfolded protein responses.
    Campestrini J; Silveira DB; Pinto AR
    Cell Biochem Funct; 2018 Oct; 36(7):377-386. PubMed ID: 30246458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade.
    Mediouni S; Watkins JD; Pierres M; Bole A; Loret EP; Baillat G
    J Biol Chem; 2012 Apr; 287(15):11942-50. PubMed ID: 22362765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.
    Dabrowska A; Kim N; Aldovini A
    J Immunol; 2008 Dec; 181(12):8460-77. PubMed ID: 19050264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
    Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
    J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: a potential molecular mechanism to escape TRAIL cytotoxicity.
    Gibellini D; Re MC; Ponti C; Vitone F; Bon I; Fabbri G; Grazia Di Iasio M; Zauli G
    J Cell Physiol; 2005 Jun; 203(3):547-56. PubMed ID: 15573381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
    Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
    Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
    Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.